Crack cocaine, alcohol, and other drug use patterns among homeless persons with other mental disorders.

Crack cocaine, alcohol, and other drug use patterns among homeless persons with other mental disorders.
复制标题

破解患有其他精神障碍的无家可归者的可卡因、酒精和其他药物使用模式。

DOI:
10.1081/ada-100103121
复制
发表时间:
2001
期刊:
The American journal of drug and alcohol abuse
影响因子:
--
通讯作者:
Michael,M
Michael,M
中科院分区:
--
文献类型:
--
作者:
Usdan,SL;Schumacher,JE;Milby,JB;Wallace,D;McNamara,C;Michael,M

文献摘要

相似文献

这项研究调查了寻求治疗的无家可归者中可卡因、酒精、大麻和其他药物使用的共同情况,以确定酒精使用预测可卡因使用是否与大麻和其他药物预测可卡因使用不同。参与者是141名有药物使用和其他非精神病精神障碍的无家可归者,他们在一家为无家可归者提供的大都市卫生保健机构寻求药物治疗。男性72.3%,女性27.7%,非裔美国人82.7%,高加索人17.3%,平均年龄37.7岁(SD 7.1),平均受教育年限13.1年(SD 2.4)。结果支持这样的断言,即可卡因的使用与酒精的使用程度密切相关,可卡因和酒精之间的联系比可卡因和包括大麻在内的其他药物使用之间的联系更强。有可卡因和酒精障碍的参与者比只有可卡因障碍的参与者在治疗中停留的时间更长,在戒断结果方面没有差异。这些发现应该会推动进一步研究酒精作为可卡因使用的触发或预测因素,可卡因和酒精联合使用的有害影响,以及对多物质使用者的专门治疗。
This study examined the co-occurrence of cocaine, alcohol, marijuana, and other drug use among treatment seeking homeless persons to determine whether alcohol use predicted cocaine use differently than marijuana and other drugs predicted cocaine use. Participants were 141 homeless persons with substance use and other nonpsychotic mental disorders seeking drug treatment at a metropolitan health care agency for homeless persons. They were 72.3% male, 27.7% female, 82.7% African American, 17.3% Caucasian, with an average age of 37.7 (SD 7.1) years and had 13.1 (SD 2.4) average years of education. Results supported the assertion that cocaine use was strongly associated with extent of alcohol use and that the association between cocaine and alcohol was stronger than the association between cocaine and other drug use, including marijuana. Participants with cocaine plus alcohol disorders were retained longer in treatment than disorders of cocaine only with no differences in abstinence outcome. The findings should drive further research into the use of alcohol as a trigger or predictor of cocaine use, the deleterious effects of the combined use of cocaine and alcohol, and specialized treatments for polysubstance users.